This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Glenmark Pharmaceuticals S.a., Glenmark Pharmaceuticals Limited. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ahmedabad, IN (2013 - 2016)
- Navi Mumbai, IN (2016)
Company Filing History:


Years Active: 2013-2016
Title: The Innovative Journey of Bipin Parsottam Kansagra
Introduction
Bipin Parsottam Kansagra is a notable inventor based in Ahmedabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative processes for drug preparation. With a total of five patents to his name, Kansagra's work reflects his dedication to advancing medical science.
Latest Patents
Kansagra's latest patents include a process for the preparation of teneligliptin, which is crucial for managing diabetes. Additionally, he has developed amides of 2-amino-4-arylthiazole compounds and their salts, focusing on the preparation of specific salts that have potential therapeutic applications. These innovations showcase his expertise in pharmaceutical chemistry and his commitment to improving healthcare solutions.
Career Highlights
Throughout his career, Bipin Kansagra has worked with prominent companies in the pharmaceutical industry, including Glenmark Pharmaceuticals S.A. and Glenmark Pharmaceuticals Limited. His experience in these organizations has allowed him to collaborate with leading professionals and contribute to groundbreaking research and development projects.
Collaborations
Kansagra has had the opportunity to work alongside talented individuals such as Sukeerthi Kumar and Abraham Thomas. These collaborations have enriched his professional journey and fostered an environment of innovation and creativity.
Conclusion
Bipin Parsottam Kansagra's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as a key innovator. His work continues to impact the field positively, paving the way for future advancements in drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile